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A B S T R A C T
Objectives: In shared decision making it is important to adequately, timely and actively involve patients in
treatment decisions. Sharing prognostic information can be of key importance. This study describes whether and
how prognostic information on life expectancy is included during communication on diagnosis and treatment
plans between physicians and head and neck (H&N) oncologic patients in diﬀerent phases of disease.
Methods: A descriptive, qualitative study was performed of n= 23 audiotaped physician-patient conversations
in which both palliative and curative treatment options were discussed and questions on prognosis were ex-
pected. Verbatim transcribed consultations were systematically analyzed. A distinction was made between
prognostic information that was provided (a) quantitatively: by giving numerical probability estimates, such as
percentages or years or (b) qualitatively: through the use of words such as ‘most likely’ or ‘highly improbable’.
Results: In all consultations, H&N surgeons provided some prognostic information. In 5.9% of the provided
prognostic information, a quantitative method was used. In 94.1% prognostic information was provided qua-
litatively, using six identiﬁed approaches. H&N surgeons possibly aﬀect patients’ perception of prognostic
content with two identiﬁed communication styles: directive (more physician-centered) and aﬀective (more
patient-centered).
Conclusion: This study is ﬁrst in providing examples of how H&N surgeons communicate with their patients
regarding prognosis in all stages of disease. They often exclude speciﬁc prognostic information. The study
outcomes can be used as a ﬁrst step in developing a guideline for sharing prognostic information in H&N on-
cologic patients, in order enable the process of shared decision making.
Introduction
During the last decade patient centered communication and patient
involvement in treatment decisions has become an important approach
in clinical care [1]. The shared decision making approach (SDM) is
considered to be a central component of treatment decision consulta-
tions [2]. Patients need to be well-informed in order to be able to be
actively involved in treatment decisions [3]. Prognostic information
may be a valuable factor in considering treatment options [4]. Besides
content, the communication style within the professional setting is also
important, especially since patients tend to remember only 20–60% of
the information provided by their physician [5,7,8]. Furthermore, when
patients do not fully understand their illness, prognosis and treatment
options and physicians do not suﬃciently elicit patients’ values, this can
worsen their physical and psychological suﬀering [9].
The SDM approach is getting more attention in treatment decision
consultations with head and neck (H&N) cancer patients [10]. The 5-
year survival rates of H&N cancer remain around 50% [11]. Also, the
commonly used treatment modalities are associated with high mor-
bidity and impact on quality of life [12]. Especially in the case of
treatment options with a direct impact on important functions, invol-
ving swallowing, taste or speech, there might be a diﬃcult trade-oﬀ
between life expectation or cure and quality of life. Therefore prog-
nosis, morbidity and quality of life of H&N cancer patients can be sig-
niﬁcant topics in doctor-patient communication, especially in con-
sultations during which treatment options are discussed.
However, communication on prognosis is diﬃcult. Many physicians
experience this particular task as distressing [13–15]. They avoid con-
versations addressing prognosis for many reasons, most frequently due
to uncertainty about the actual prognosis or how to communicate this.
Other reasons are lack of training, insuﬃcient time to attend to the
patient’s emotional needs, and fear of a negative impact on the patient
[14,16]. As a result, some physicians discuss prognosis in vague or in
optimistic terms, avoid the topic unless the patient insists, or mainly
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focus the discussion on treatment options. Estimates of prognosis pro-
vided by physicians are also often overly optimistic when compared to
actual or predicted outcomes [17–19]. On the other hand, interpreta-
tion of prognostic information by patients may range from unrealistic
optimism to the belief that one will be the patient who experiences the
bad outcome described [20].
The way physicians provide prognostic information is of vital im-
portance. Some rely on qualitative statements (e.g., ‘‘I think he is unlikely
to survive’’), whereas others use quantitative or numeric expressions
(e.g., ‘‘80% of patients in this situation do not survive’’) [21]. Likewise, the
framing of prognostic information, either positive or negative, might be
diﬀerent among physicians (e.g., “the chance of survival is 20%” versus
“the chance that you’ll die will be 80%”). Lastly, physician communica-
tion style can diﬀer, either being directive (e.g., telling the patient what
to do) or aﬀective (e.g., autonomy supportive) [22]. Research has
shown that providing suﬃcient quantitative information allows pa-
tients to make fully informed decisions in contrast to providing solely
qualitative information [4,21,23]. Also, giving numeric expressions of
prognosis improves the accuracy of patients’ risk perceptions and the
comfort with feeling informed [23].
Most research in the ﬁeld of communication of prognosis in cancer
care focuses on end of life or palliative care. This is also the case for H&
N cancer [24–26]. However, improving prognostic understanding is
important during all stages of disease. The literature lacks information
on communication of prognosis in H&N cancer patients, especially on
those with curative treatment options.
This study’s primary purpose is to investigate whether prognostic
information on life expectancy is included during communication on
diagnosis and treatment plans between physicians and H&N oncologic
patients in all phases of the disease. We also want to describe the
communication style displayed by physicians as this can aﬀect patients’
perceptions of prognostic content.
Methods
We performed a qualitative single-center descriptive study based on
audio-taped real physician-patient consultations in which treatment
options were discussed and questions on prognosis were to be expected.
A qualitative approach is most suitable for in depth investigating health
care issues in context and for taking into account interaction, behavior,
and perceptions within groups [27].
Consultations
In this study, n=31 patients were approached to record the con-
sultation with their physician. Patients were eligible if they received a
treatment proposal for their recently diagnosed H&N cancer, regardless
of the phase (curative/palliative) of their disease. Patients were re-
cruited at the out-patient clinic of the Erasmus MC Cancer Institute and
received oral and written counselling about this study by an in-
dependent researcher before entering the consultation with their phy-
sician. Written informed consent was obtained following guidelines of
the Medical Ethical Committee. N= 23 patients gave their consent and
the consultations between them and n= 7 physicians were digitally
recorded. Eight patients declined participation in this study due to
privacy reasons. The seven physicians were all H&N cancer surgeons
with relevant experience varying between 5 and 30 years.
Deﬁnition of prognostic information
Prognosis was deﬁned as life expectancy, survival and the prospect
of cure as anticipated from the usual course of disease. We made a
distinction between prognostic information that was provided quanti-
tatively by giving numerical probability estimates such as percentages
or years or qualitatively through use of words or phrases such as ‘most
likely’, ‘frequent’ or ‘highly improbable’.
Analytic procedures
All verbatim transcribed consultations were analyzed by three in-
dependent researchers (ED, MB and MO) using a constant comparative
technique [28]. Two researchers (ED and MO) who were trained in this
technique initially made independent assessments of the ﬁrst 7 con-
sultations separately, assuring that all audiotaped H&N surgeons were
included at least once. Both researchers detected prognostic informa-
tion provided by H&N surgeons and wrote short descriptions of the
diﬀerent phrases used to share prognostic information (quantitatively
or qualitatively). All highlighted passages have been reviewed and
discussed in detail by the researchers in order to reach consensus. In the
next assessment saturation of the qualitative study approach was
reached after discussing 13 more consultations. No additional prog-
nostic content besides the known qualitative and quantitative ap-
proaches regarding prognosis could be identiﬁed. Apart from the
method of providing prognostic information, the communication style
or professional attitude of H&N surgeons that can aﬀect patients’ per-
ception of prognostic content, was described. We made a distinction
between directive and aﬀective communication styles. The directive
communication style is more physician-centered, while the aﬀective
communication style is more supportive and patient-centered [21,23].
A third researcher (MB) veriﬁed the results by coding n= 7 transcribed
consultations that were randomly selected.
At the end of this procedure, the researchers found a few examples
that were classiﬁed diﬀerently by each researcher. After an in-depth
discussion, consensus was reached. The results were subsequently ra-
tionalized into a coding frame that was applied to all transcripts, using
NVivo qualitative software (version 10). Furthermore, the primary in-
itiator of the discussion about prognosis in each consultation was
documented, either being the patient, the caregiver or the H&N sur-
geon. Also the time used to communicate the prognosis in the con-
sultation was recorded.
Results
Characteristics of participants and consultations
Twenty three patients participated in this study, with an average
age of 68 years. Most patients (87%) received a curative treatment plan
(see Table 1).
Mean total duration of consultations was 14min and 21 s (SD 9min
1 s). The mean time used for discussing a quantitative prognosis was
38 s (SD 35 s), accounting for 4.4% of the consultations. H&N surgeons
were the primary initiators in 58% of discussions about prognosis, pa-
tients in 18% and caregivers in 24%.
Provision of prognostic information
In all n= 23 consultations, H&N surgeons provided some prog-
nostic information. We found a total of n=222 quotations containing
Table 1
Patient characteristics.
Number of patients % of total number of patients
Men 17 74%
Women 6 26%
Age (years)
50–59 6 26%
60–69 9 39%
70–79 5 22%
>80 3 13%
Intention of treatment
Curative 20 87%
Palliative 3 13%
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prognostic information. In seven interviews, n=13 quotations (5.9%)
demonstrating a quantitative method using clear numerical prob-
abilities were identiﬁed. An example of this method:
H&N surgeon: You can say that the probability of you living for one
more year is not big. That chance that you will live to 90 is considerably
smaller. If I had to predict, I would say that you have a 30% to 40%
more chance compared to those in your age group who presently get
nothing. Not 0 though if it was at 0 we would not do anything.
In all n= 23 consultations, prognosis of the disease and its treat-
ment was provided in a qualitative manner (n= 209 quotations,
94.1%) (see Fig. 1a) In 30% of the interviews quantitative and quali-
tative methods were combined to deliver the prognostic message. In
case of a qualitative method H&N surgeons varied communication ap-
proaches to share the prognostic content. We identiﬁed six diﬀerent
qualitative prognostic communication approaches: (1) bad news/good
news ﬂow (9%), (2) positive framing (18%), (3) negative framing
(28%), (4) implicit prognosis (8%), (5) general counselling (11%) and
(6) scenario analysis (20%) (see Fig. 1b). Examples are shown in
Table 2.
The ‘bad news/good news ﬂow’ approach is characterized by good
news and bad news being used in an alternating order resulting in
possible uncertainty about the prognostic tendency of the provided
information: positive or negative? (example 1, Table 2).
In the ‘positive framing’ approach the positive aspects of prognosis
are emphasized (example 2, Table 2) The negative aspects regarding
prognosis are underlined in the ‘negative framing’ approach (example 3,
Table 2). The use of an ‘implicit prognosis’ approach (example 4,
Table 2) is illustrative for a qualitative method of providing prognostic
information. An approximation or ambiguous description of prognosis
of the individual patient is used, thus implicitly providing prognostic
information without being speciﬁc. An example of this method:
H&N surgeon: Now that means that... yes... your life expectancy
through this has naturally changed slightly. Look, for you is has become
like heads or tails; either you will survive or you will not. However if you
a) 
b) 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Qualitative prognostic information
Quantitative prognostic information
Communicating prognostic information
0% 5% 10% 15% 20% 25% 30%
Negative framing
Positive framing
Scenario analysis
General counselling
Bad news/ good news flow
Implicit prognosis
Qualitative prognostic information approaches
Fig. 1. Quantitative and qualitative approaches of prognostic information.
Table 2
Identiﬁed prognostic communication approaches used by physicians.
Approach (1) Bad news good news ﬂow:
Example: “The last time I saw you, you were not looking well. That is the reason for the
scan and ultrasound. The tongue looks good and the throat is also completely ﬁne, only
in the scan there is still a small lymph node visible in the neck.”
Approach (2) Positive framing:
Example: “Now luckily for you radiation treatment only will probably be enough”.
Approach (3) Negative framing:
Example: “You see the only thing I can do is a big operation with a lot of risk and a small
chance of success and I do not think that is realistic as we are then making you worse
than you are now. The risk are.. that there are huge blood vessels…you may become
paralyzed on one side…you will end up in a wheel chair and a nursing home.”
Approach (4) Implicit prognosis:
Example: “Now that means that, yes, your life expectancy through this has naturally
changed slightly. Look, for you is has become like heads or tails either you will survive
or you will not. However if you look at it with a group of patients then there will
obviously be a few patients that will indeed pass away because of this problem…that is
exactly what is happening now.”
Approach (5) General counselling:
Example: “You have stopped smoking right? Yes thankfully, as that is very important…as
that gives you a greater chance of getting back into the good group, as we know that
people that continue to smoke have worse expectancies.”
Approach (6) Scenario analysis:
Example: “Another option is not a curative treatment. You can decide only to radiate but
that will be to keep the tumor under control, reduce symptoms and slow it down.
However because of the tongue tumor we do not expect you to survive.”
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look at it with a group of patients then there will obviously be a few
patients that will indeed pass away because of this problem...that is ex-
actly what is happening now.
In the ‘general counselling’ approach general information about the
course disease or treatment in a general population with regard to
prognosis is given. The ﬁnal qualitative approach that could be iden-
tiﬁed is ‘scenario analysis’ (example 6, Table 2). Prognostic information
on a ‘what if’ scene is provided. In this situation general conditions are
outlined that could be the case for the individual patient.
Examples of diﬀerent communication styles displayed by physicians
H&N surgeons possibly aﬀect patients’ perception of prognostic
content with two identiﬁed communication styles: directive (more
physician-centered) and aﬀective (more patient-centered). Several ex-
amples of the directive communication style were found (Table 3), such
as the paternalistic professional attitude and the use of medical jargon
during patient-physician communication.
In the ﬁrst example, the H&N surgeon has already decided - with
best intentions - which treatment option is the best for the patient. The
second example shows the use of medical jargon which can lead to one-
way communication in which patients might feel by-passed.
We found examples of the more patient-centered aﬀective commu-
nication style that were characterized by giving hope or by a compas-
sionate tone of voice. Diminutive words were used along with the af-
fective communication style. Those words appeared to alleviate the
harsh message, but could also be misleading when serious subjects such
as ‘tumor’ or ‘treatment plan’ were discussed (Table 4). In example 1,
the physician supports the patient to take part in the decision process.
In example 2, the physician is trying to provide hope to the patient.
Finally, example 3 illustrates the use of diminutive words as discussed
above.
Discussion
To our knowledge, this study is ﬁrst in describing whether and how
prognostic information is included during communication on diagnosis
and treatment plans between H&N surgeons and their H&N oncologic
patient in all phases of disease. Research has shown that providing
suﬃcient quantitative information on life-expectancy allows patients to
make fully informed decisions [2,21,23]. In this study our qualitative
analysis revealed that only 5.9% of the provided prognostic information
included in the treatment and decision consultations was given quan-
titatively. In the majority of cases (94.1%) a variety of qualitative
methods was used. Positive and negative framing were mostly used
(46%). The same prognostic content could be interpreted diﬀerently
using these framing approaches. With positive framing patients might
interpret the information unrealistically optimistic and with negative
framing patients might believe that they will be the ones with the bad
outcome. A combination of these two approaches is found in the ‘bad
news/good news ﬂow’ (9%), where good and bad news are used in an
alternating order, potentially resulting in insecurity about the prog-
nostic tendency of the provided information: “am I going to be all right or
not?”. The same might happen with a ‘general counselling’ approach
(11%) or ‘scenario analysis’ approach (20%) where the prognostic in-
formation is general and not tailor-made to the patients speciﬁc situa-
tion. The ‘implicit prognosis’ approach was seen in the minority (8%) of
the qualitative approaches, while being closest to the prognostic value
of the explicit quantitative approach.
Overall, we found that diﬀerent communication approaches were
used during one encounter in a rapid alternating order. Given the fact
that patients tend to remember only 20–60% of the information pro-
vided by their physician, they may feel so overwhelmed by the amount
of information, one can question if they adapted the useful part [8].
Why is an explicit quantitative prognostic communication strategy
being used in a minority of the cases? Given the 4.4% of the total time
of conversations that H&N surgeons communicate prognostic informa-
tion in numerical probabilities, there might be a reluctance to do so.
First, this could be due to a lack of reliable prognostic information,
which is in agreement with earlier research. Prognostic judgments by
physicians tend to be inaccurate and optimistically biased [18,19]. In H
&N oncology, estimation of prognosis is based on the American Joint
Committee on Cancer (AJCC) TNM staging classiﬁcation. This objective
and accurate tool is used to predict prognosis for an entire population of
patients. However, it is ineﬀective for predicting outcomes in an in-
dividual patient, not taking into account the role of other tumor factors
and important patient characteristics such as comorbidity or tobacco
use [19,29]. In order to improve predictions, prognostic models for H&
N oncologic patients are developed based on multivariate survival
analyses of large datasets [30–32]. These tools could help physicians
with patient counselling and deciding on treatment options.
Secondly, it will take time and eﬀort to identify patients’ pre-
ferences about receiving prognostic information. Literature shows that
patients desire accurate estimates of prognosis in order to allow them to
make decisions that are consistent with their values [5,33,34]. On the
other hand, patients desire, above all, to maintain hope for their si-
tuations, or do not want to receive information about their prognosis at
all [5,35,36]. That ‘management of hope’ permits the physician to take
some liberties with prognostic estimates. Obviously, there is some
tension between these two views and as mentioned before the majority
of available studies focus on patients in the palliative phase of their
disease [33–36]. As we used a qualitative study design, no deductions
could be made about predisposing factors that could predict patient
preferences on wanting prognostic information or not.
Furthermore, the right timing of sharing prognostic information is
key. This is part of the professional attitude each physician possesses
and the relationship built with the patient. However it is diﬃcult for
physicians to predict patients’ values or preferences [37]. There is no
consensus in literature on this topic. One study reported that 84% of
patients with metastatic disease wanted to discuss treatment goals and
options when ﬁrst diagnosed, and only 59% wanted to discuss survival
at that time [5]. Another study showed that common sense or intuition
should guide physicians when to raise prognostic discussions [6]. Pa-
tients preferred their doctors to raise the topic of prognosis early on, as
not to question the timing of raising it themselves. Physicians see
communicating prognosis as a process rather than a conversation trig-
gered by certain circumstances, such as upon diagnosis [25]. Literature
shows that younger and more educated patients are associated with
Table 3
Examples of directive communication style.
Example 1 – Paternalistic professional attitude:
H&N surgeon: “In the meantime many things have been set in motion for you…I had
already requested the surgery and there is already a date planned for you.”
Example 2 – Use of medical jargon:
H&N surgeon: “Yes it is now at the T3 stage so the protocol will without a doubt say
PORT.”
Table 4
Examples of aﬀective communication style.
Example 1 – Patient empowering professional attitude:
H&N surgeon: “So we think that yes we can consider the radiation treatment. If this is
what you want… as you are naturally the boss… if we say something and you do not
want that, that is also ﬁne. It is your life.”
Example 2 – Giving hope:
H&N surgeon: “One abnormality yes but again it could be a false alarm.”
Example 3 – Use of diminutive words and euphemisms:
H&N surgeon: “Yes…the X-ray was naturally not made for nothing as there are some
small problems with your lungs…and…”
Patient: “Of course, I coughed up blood.”
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wanting a high level of prognostic information [38–40]. Caregivers
favored full patient involvement in decision making, while patients
were divided between wanting autonomy and a more passive approach
[24].
Finally, professional communication skills explain the limited use of
explicit prognostic communication. Communication styles may diﬀer
and might aﬀect patients’ perception of the prognostic content. Most
studies emphasize the importance of the communication style as fre-
quently as the content [5–7]. This is underlined by our ﬁndings on
professional attitude. For physicians, it sometimes seemed to be a
struggle ﬁnding the right words and tone of voice. Accurate information
is preferred, as long as it is not delivered bluntly or with too much hard
factual or detailed information [5–7]. It is reasonable that physicians
try to oﬀer hope to cancer patients. However, a realistic perspective,
including a small amount of ‘negative’ information about the course of
disease, can help patients gain a more balanced perception of their
prognosis and subsequently experience less anxiety and distress
[33,39,41]. In conﬁrmation with literature, patients favor information
conveyed in a compassionate and empathic manner [42]. Patients
prefer information given in a digestible manner using appropriate
language, avoiding medical jargon [43]. In addition, information may
need to be repeated on diﬀerent occasions to meet patient’s individual
needs and to prevent the ‘one-way-process’ of overwhelming the patient
with information and diﬀerent communication strategies [44].
Strengths and limitations
The major strength of this study is that it gives a unique insight
behind closed doors. Insight is gained in otherwise private consultations
between H&N surgeons and their patients. Another strength is that we
included patients with all stages of disease. At the same time this is a
limitation of the study because life expectancy and therefore prognosis
is inevitably worse in patients in the palliative phase of disease. As
patients volunteered to partake in this study it is possible that the re-
sults of this study represent the more ‘engaged’ patients and caregivers;
those who are interested in prognosis and quality of life, and present a
participating attitude during the consultation. Additionally bias could
be introduced as physicians are aware their conversations are regis-
tered. Despite these limitations, the study results add to an under-
exposed subject and enabled us to better understand communication of
prognosis in patients with H&N cancer.
Practice implications
Based on our results and discussion of the topic, we prepared ﬁrst
steps for a guideline for sharing prognostic information in H&N on-
cology practice (Table 5). These suggested steps are meant as a stimulus
to encourage sharing prognostic communication in a clinical setting.
We recommend to provide written information on treatment options to
assist patients and caregivers with retaining information and to over-
come the ‘one-way-process’ whereby a physician provides a large
amount of information to patients [45]. Additionally, the presence of a
case manager or an additional visit to an oncology nurse could be of
added value to both patient as H&N surgeon. This is an easy accessible
professional who can take some more time with the patient in order to
clarify and conﬁrm the physician’s message.
Conclusion
This study is ﬁrst in providing examples of how H&N surgeons
communicate with their patients regarding prognosis in all stages of
disease. Understanding the diﬃculties of communicating prognosis will
take us a step further into our strive for patient-centered counselling
and shared decision making. This study points out that speciﬁc quan-
titative prognostic information is often not included in communication
between H&N oncologic surgeons and their patients and diﬀerent
qualitative methods are used instead. Doctors should be aware of both
their communication approach for discussing prognosis and their
communication as this might aﬀect patients’ understanding and per-
ception of information provided. Prognostic models can contribute to
knowledge and thus enhance patient empowerment and make shared
decision possible.
Future research
With this study we add to an underexposed subject of research on
prognostic communication in head and neck oncologic patients.
However there is a need for creating patient-preference studies, starting
research on the eﬃcacy of our suggested approach of prognostic com-
munication and developing decision aids for patients and caregivers. In
our clinic we have started a study based on focus group methodology to
discover patient preferences in prognostic communication. There is
limited data on eﬀective teaching methods to promote long-term
change of communication skills. Research should focus on whether
feedback is an essential element and how best to incorporate decision
aids into conversations. Finally, development of reliable, internally and
externally validated sophisticated prognostic models is needed to sup-
port physicians in providing tailor-made prognostic information to their
patients.
Funding
This research did not receive any speciﬁc grant from funding
agencies in the public, commercial, or not-for-proﬁt sectors.
Conﬂicts of interest
None declared.
Acknowledgements
We would like to thank all patients and physicians for taking part in
this study and a special thanks to Rose Willis and Catherine Mc Duling
Krijger for their linguistic corrections.
References
[1] Tariman JD, Berry DL. Preferred and actual participation roles during health care
decision making in persons with cancer: a systematic review. Ann Oncol
2010;21:1145–51.
[2] Elwyn G, Coulter A, Laitner S, Walker E, Watson P, Thomson R. Implementing
shared decision making in the NHS. BMJ 2010;341:c5146.
[3] Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter:
what does it mean? (or it takes at least two to tango). Soc Sci Med
1997;44(5):681–92.
[4] Lagarde SM, Franssen SJ. Patient preferences for the disclosure of prognosis after
esophagectomy for cancer with curative intent. Ann Surg Oncol
2008;15(11):3289–98.
[5] Hagerty RG, Butow PN, Ellis PM, Lobb EA, Pendlebury SC, Leighl N, et al.
Communicating with realism and hope: incurable cancer patients' views on the
disclosure of prognosis. J Clin Oncol 2005;23(6):1278–88. https://doi.org/10.
1200/JCO.2005.11.138.
[6] Clayton JM, Butow PN, Tattersall MH. When and how to initiate discussion about
Table 5
Guideline for sharing prognostic information in H&N oncology practice.
Step 1: Explore patient preferences on receiving prognostic information
Step 2: Assure there is accurate or as personal as possible information on the
prognosis of the individual patient
Step 3: Initiate a conversation about life expectancy
Step 4: Use prognostic information in an empathic, honest and digestible way
Step 5: Avoid use of a directive communication style; yet give a realistic perspective
of prognosis
Step 6: Recognize prognostic communication as a process and if needed repeat
information on diﬀerent occasions
E.A.C. Dronkers et al. Oral Oncology 84 (2018) 76–81
80
prognosis and end-of-life issues with terminally ill patients. J Pain Symptom
Manage 2005;30(2):132–44. https://doi.org/10.1016/j.jpainsymman.2005.02.014.
[7] Coyle N, Sculco L. Communication and the patient/physician relationship: a phe-
nomenological inquiry. J Support Oncol 2003;1(3):206–15.
[8] Medendorp NM, Visser LNC. How oncologists’ communication improves (analogue)
patients’ recall of information. a randomized video-vignettes study. Patient Educ
Couns 2017;100(7):1338–44.
[9] Tulsky JA, Beach MC, Butow PN, Hickman SE, Mack JW, Morrison RS, et al. A
research agenda for communication between health care professionals and patients
living with serious illness. JAMA Intern Med 2017(July). https://doi.org/10.1001/
jamainternmed.2017.2005.
[10] Heuvell van den, Linden C Van, Zuuren F van. Paradigm shift in head and neck
oncology patient management. J Otolaryngol Head Neck Surg 2017;46(1):57.
[11] Braakhuis BJ, Leemans CR, Visser O. Incidence and survival trends of head and neck
squamous cell carcinoma in the Netherlands between 1989 and 2011. Oral Oncol
2014;50(7):670–5. https://doi.org/10.1016/j.oraloncology.2014.03.008. [Epub
2014 Apr 13].
[12] Rogers SN, Hogg ES, Cheung WK, Lai LK, Jassal P, Lowe D, et al. 'What will I be like'
after my diagnosis of head and neck cancer? Eur Arch Otorhinolaryngol
2015;272(9):2463–72. https://doi.org/10.1007/s00405-014-3189-x. [Epub 2014
Jul 22].
[13] Graner KM, Rolim GS, Moraes ABA, Padovani CR, Lopes MA, Santos-Silva AR, et al.
Feelings, perceptions, and expectations of patients during the process of oral cancer
diagnosis. Support Care Cancer 2016;24(5):2323–32. https://doi.org/10.1007/
s00520-015-3030-0. [Epub 2015 Nov 27].
[14] Hancock K, Clayton JM, Parker SM, Wal der S, Butow PN, Carrick S, et al. Truth-
telling in discussing prognosis in advanced life-limiting illnesses: a systematic re-
view. Palliat Med 2007;21(6):507–17. https://doi.org/10.1177/
0269216307080823.
[15] Rogg L, Loge JH, Aasland OG, Graugaard PK. Physicians' attitudes towards dis-
closure of prognostic information: a survey among a representative cross-section of
1605 Norwegian physicians. Patient Educ Couns 2009 Nov;77(2):242–7. https://
doi.org/10.1016/j.pec.2009.03.007. [Epub 2009 Apr 8].
[16] Almack K, Cox K, Moghaddam N, Pollock K, Seymour J. After you: conversations
between patients and healthcare professionals in planning for end of life care. BMC
Palliat Care 2012;17(11):15. https://doi.org/10.1186/1472-684X-11-15.
[17] The AM, Hak T, Koëter G, van Der Wal G. Collusion in doctor-patient commu-
nication about imminent death: an ethnographic study. BMJ
2000;321(7273):1376–81.
[18] Christakis NA, Lamont EB. Extent and determinants of error in doctors' prognoses in
terminally ill patients: prospective cohort study. BMJ 2000;320(7233):469–72.
[19] van der SchroeﬀMP, van Schie K, Langeveld TP, Looman C, Baatenburg de Jong RJ.
Model-assisted predictions on prognosis in HNSCC: do we learn? Eur Arch
Otorhinolaryngol 2010;267(9):1445–8. https://doi.org/10.1007/s00405-010-
1251-x. [Epub 2010 Apr 17].
[20] Hagerty RG, Butow PN, Ellis PA, Lobb EA, Pendlebury S, Leighl N, et al. Cancer
patient preferences for communication of prognosis in the metastatic setting. J Clin
Oncol 2004;22(9):1721–30. https://doi.org/10.1200/JCO.2004.04.095.
[21] Lee Char SJ, Evans LR, Malvar GL, White DB. A randomized trial of two methods to
disclose prognosis to surrogate decision makers in intensive care units. [Epub 2010
Jun 10]. Am J Respir Crit Care Med 2010;182(7):905–9. https://doi.org/10.1164/
rccm.201002-0262OC.
[22] Martinez K, Resnicow K. Does physician communication style impact patient report
of decision quality for breast cancer treatment? Patient Educ Couns
2016;99(12):1947–54.
[23] Man-Son-Hing Malcolm. The eﬀect of qualitative vs. quantitative presentation of
probability estimates on patient decision-making: a randomized trial. Health Expect
2002;5(3):246–55.
[24] O'Sullivan EM, Higginson IJ. 'I'll continue as long as I can, and die when I can't help
it': a qualitative exploration of the views of end-of-life care by those aﬀected by
head and neck cancer (HNC). BMJ Support Palliat Care 2016;6(1):43–51. https://
doi.org/10.1136/bmjspcare-2014-000664. [Epub 2014 May 13].
[25] Roscoe LA, Tullis JA, Reich RR, McCaﬀrey JC. Beyond good intentions and patient
perceptions: competing deﬁnitions of eﬀective communication in head and neck
cancer care at the end of life. Health Commun 2013;28(2):183–92. https://doi.org/
10.1080/10410236.2012.666957. [Epub 2012 May 10].
[26] Sciubba JJ. End of life considerations in the head and neck cancer patient. Oral
Oncol 2009;45(4–5):431–4. https://doi.org/10.1016/j.oraloncology.2008.06.001.
[Epub 2008 Sep 18].
[27] Bousquet G, Orri M, Winterman S, Brugière C, Verneuil L, Revah-Levy A. Breaking
bad news in oncology: a metasynthesis. J Clin Oncol 2015;33(22):2437–43. https://
doi.org/10.1200/JCO.2014.59.6759. [Epub 2015 Jun 29].
[28] Strauss A, Corbin J. Basics of qualitative research: grounded theory procedures and
techniques. London: SAGE Publications; 1990.
[29] Patel SG, Lydiatt WM. Staging of head and neck cancers: is it time to change the
balance between the ideal and the practical? J Surg Oncol 2008;97(8):653–7.
https://doi.org/10.1002/jso.21021.
[30] Datema FR, Ferrier MB, Vergouwe Y, Moya A, Molenaar J, Piccirillo JF, Baatenburg
de Jong RJ. Update and external validation of a head and neck cancer prognostic
model. Head Neck 2013;35(9):1232–7. https://doi.org/10.1002/hed.23117. [Epub
2012 Jul 30].
[31] Montero PH, Yu C, Palmer FL, Patel PD, Ganly I, Shah JP, et al. Nomograms for
preoperative prediction of prognosis in patients with oral cavity squamous cell
carcinoma. Cancer 2014;120(2):214–21. https://doi.org/10.1002/cncr.28407.
[Epub 2013 Oct 25].
[32] van der Schroeﬀ MP, Steyerberg EW, Wieringa MH, Langeveld TP, Molenaar J,
Baatenburg de Jong RJ. Prognosis: a variable parameter: dynamic prognostic
modeling in head and neck squamous cell carcinoma. Head Neck
2012;34(1):34–41. https://doi.org/10.1002/hed.21693. [Epub 2011 Feb 14].
[33] Helft PR. Necessary collusion: prognostic communication with advanced cancer
patients. J Clin Oncol 2005;23(13):3146–50. https://doi.org/10.1200/JCO.2005.
07.003.
[34] Lamont EB, Christakis NA. Complexities in prognostication in advanced cancer: “to
help them live their lives the way they want to”. JAMA 2003;290(1):98–104.
https://doi.org/10.1001/jama.290.1.98.
[35] Weeks JC, Cook EF, O'Day SJ, Peterson LM, Wenger N, Reding D, et al. Relationship
between cancer patients' predictions of prognosis and their treatment preferences.
JAMA 1998;279(21):1709–14.
[36] Kodish E, Post SG. Oncology and hope. J Clin Oncol 1995;13(7):1817. https://doi.
org/10.1200/JCO.1995.13.7.1817.
[37] Mulley AG, Trimble C, Elwyn G. Stop the silent misdiagnosis: patients' preferences
matter. BMJ 2012;345(November):e6572. https://doi.org/10.1136/bmj.e6572.
[38] Parker SM, Clayton JM, Hancock K, Walder S, Butow PN, Carrick S, Currow D,
Ghersi D, Glare P, Hagerty R, Tattersall MH. A systematic review of prognostic/end-
of-life communication with adults in the advanced stages of a life-limiting illness:
patient/caregiver preferences for the content, style, and timing of information. J
Pain Symptom Manage 2007;34(1):81–93. https://doi.org/10.1016/j.
jpainsymman.2006.09.035. [Epub 2007 May 25].
[39] Fallowﬁeld LJ, Jenkins VA, Beveridge HA. Truth may hurt but deceit hurts more:
communication in palliative care. Palliat Med 2002;16(4):297–303. https://doi.
org/10.1191/0269216302pm575oa.
[40] Hagerty RG, Butow PN, Ellis PM, Dimitry S, Tattersall MH. Communicating prog-
nosis in cancer care: a systematic review of the literature. Ann Oncol
2005;16(7):1005–53. https://doi.org/10.1093/annonc/mdi211. [Epub 2005
Jun 6].
[41] Leydon GM, Boulton M, Moynihan C, Jones A, Mossman J, Boudioni M, et al.
Cancer patients' information needs and information seeking behaviour: in depth
interview study. BMJ 2000;320(7239):909–13.
[42] Kirk P, Kirk I, Kristjanson LJ. What do patients receiving palliative care for cancer
and their families want to be told? A Canadian and Australian qualitative study.
BMJ 2004;328(7452):1343. https://doi.org/10.1136/bmj.38103.423576.55.
[Epub 2004 May 19].
[43] Yardley SJ, Davis CL, Sheldon F. Receiving a diagnosis of lung cancer: patients'
interpretations, perceptions and perspectives. Palliat Med 2001;15(5):379–86.
https://doi.org/10.1191/026921601680419429.
[44] Repetto L, Piselli P, Raﬀaele M, Locatelli C. GIOGer Communicating cancer diag-
nosis and prognosis: when the target is the elderly patient-a GIOGer study. Eur J
Cancer 2009;45(3):374–83. https://doi.org/10.1016/j.ejca.2008.08.020. [Epub
2008 Oct 4].
[45] Jabbour J, Milross C, Sundaresan P, Ebrahimi A, Shepherd HL, Dhillon HM, et al.
Education and support needs in patients with head and neck cancer: a multi-in-
stitutional survey. Cancer 2017;123(11):1949–57. https://doi.org/10.1002/cncr.
30535. [Epub 2017 Jan 12].
E.A.C. Dronkers et al. Oral Oncology 84 (2018) 76–81
81
